Baxter International Inc. BAX

23.37 (0.11) (0.47%) as of 25 Sep
Market cap
$12.2B
P/E
0.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Baxter International Inc. (BAX) EV/Sales

As of 25 September 2026, Baxter International Inc. (BAX) trades at a EV/Sales of 1.7×. Over the past ten years it has ranged from 1.4× (March 2026) to 4.9× (February 2022); the current reading is higher than 6% of that period. That is below the Medical Instruments & Supplies industry median of 3.1× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 1.5× (37.57%)
FY2024 2.5× (15.77%)
FY2023 2.9× (27.54%)
FY2022 4.0× (15.08%)
FY2021 4.8× 28.28%
FY2020 3.7× (5.44%)
FY2019 3.9× 18.35%
FY2018 3.3× (4.11%)
FY2017 3.5× 44.92%
FY2016 2.4× 18.82%

Quarterly

Period EV/Sales Change
Jun 2026 1.6× 12.38%
Mar 2026 1.4× (7.64%)
Dec 2025 1.5× (12.87%)
Sep 2025 1.8× (17.59%)
42 more quarters

Against its own ten years

Low 1.4× High 4.9×
Ten-year median 3.3×
Current reading's percentile 6

EV/Sales against peers

Company EV/Sales
BAX Baxter International Inc. 1.7×
BLCO Bausch + Lomb Corporation compare 2.0×
AVTR Avantor, Inc. compare 2.1×
ALGN Align Technology, Inc. compare 2.3×
ATR AptarGroup, Inc. compare 2.3×
SOLV Solventum Corporation compare 2.4×
COO The Cooper Companies, Inc. compare 3.1×
STVN Stevanato Group S.p.A. compare 4.3×
RGEN Repligen Corporation compare 13.4×
Medical Instruments & Supplies industry median 3.1×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on BAX